Infusion 51a is an impact-focused investment fund on a mission to invest in, develop, and advance world-changing innovation. Initially, it seeks disruptive precision-based opportunities within the life sciences.
Infusion 51a, nestled in the heart of the US research triangle in North Carolina, is dedicated to fostering the advancement of groundbreaking health solutions worldwide.
Our focus spans a diverse array of transformative companies, ranging from targeted therapeutics to precision diagnostics, from nanotechnology to bioengineering, augmented by artificial intelligence and big data innovations.
With a seasoned team deeply entrenched in the Life Science investment sphere, we specialize in bridging visionary investors with trailblazing entrepreneurs, united by a shared commitment to effecting positive change.
We extend an invitation to visionary founders and investors to join our mission.
People
- Jeffrey Stephens, Chief Investment Officer
You last contacted this investor on .